Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study

References

• Aanouz, I., Belhassan, A., El Khatabi, K., Lakhlifi, T., El Idrissi, M., & Bouachrine, M. (2020). Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations. Journal of Biomolecular Structure and Dynamics, 1–12. (just-accepted), https://doi.org/10.1080/07391102.2020.1758790
   PubMed Web of Science ®Google Scholar
• Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses, 4(6), 1011–1033. https://doi.org/10.3390/v4061011
   PubMed Web of Science ®Google Scholar
• Bogoch, I. I., Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M. U., & Khan, K. (2020). Potential for global spread of a novel coronavirus from China. Journal of Travel Medicine, 27(2), 1–3. https://doi.org/10.1093/jtm/taaa011
   Web of Science ®Google Scholar
• Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1–14. (just-accepted), https://doi.org/10.1080/07391102.2020.1758788
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 1–15. (just-accepted), https://doi.org/10.1080/07391102.2020.1761882
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A., & Azzam, E. B. (2020). Novel Guanosine Derivatives against MERS CoV polymerase: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 1–12. (just-accepted), https://doi.org/10.1080/07391102.2020.1758789
   PubMed Web of Science ®Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1–12. (just-accepted), https://doi.org/10.1080/07391102.2020.1758791
   PubMed Web of Science ®Google Scholar
• Enayatkhani, M., Hasaniazad, M., Faezi, S., Guklani, H., Davoodian, P., Ahmadi, N., & Ahmad, K. (2020). Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study. Journal of Biomolecular Structure and Dynamics, 1–19. (just-accepted), https://doi.org/10.1080/07391102.2020.1756411
   PubMed Web of Science ®Google Scholar
• Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). “Andrographolide as a potential inhibitor of SARS-CoV-2 main protease:” An in silico approach. Journal of Biomolecular Structure and Dynamics, 1–10. (just-accepted), https://doi.org/10.1080/07391102.2020.1760136
   PubMed Web of Science ®Google Scholar
• Galante, O., Avni, Y. S., Fuchs, L., Ferster, O. A., & Almog, Y. (2016). Coronavirus NL63-induced adult respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine, 193(1), 100–101. https://doi.org/10.1164/rccm.201506-1239LE
   PubMed Web of Science ®Google Scholar
• Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 1–17. (just-accepted), https://doi.org/10.1080/07391102.2020.1751300
   PubMed Web of Science ®Google Scholar
• Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., & Shahpasand, K. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, 1–13. (just-accepted), https://doi.org/10.1080/07391102.2020.1754293
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Islam, R., Parves, R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., & Halim, M. A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–20. (just-accepted), https://doi.org/10.1080/07391102.2020.1761883
   PubMed Web of Science ®Google Scholar
• Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., & Kulkarni, M. J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure and Dynamics, 1–16. (just-accepted), https://doi.org/10.1080/07391102.2020.1760137
   Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G., Jain, M., Singh, E., Pathak, A., & Singh, A. K. (2020). Targeting SARS-Cov-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2’-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–40. (just-accepted), https://doi.org/10.1080/07391102.2020.1753577
   Web of Science ®Google Scholar
• Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–13. (just-accepted), https://doi.org/10.1080/07391102.2020.1751298
   Web of Science ®Google Scholar
• Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., & Nielsen, M. (2007). Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics, 8(1), 424. https://doi.org/10.1186/1471-2105-8-424
   PubMed Web of Science ®Google Scholar
• Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–7. (just-accepted), https://doi.org/10.1080/07391102.2020.1752802
   PubMed Web of Science ®Google Scholar
• Pant, S., Singh, M., Ravichandiran, V., Murty, U. S. N., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, 1–15. (just-accepted), https://doi.org/10.1080/07391102.2020.1757510
   PubMed Web of Science ®Google Scholar
• Prajapat, M., Sarma, P., Shekhar, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., Bansal, S., & Medhi, B. (2020). Drug targets for corona virus: A systematic review. Indian J Pharmacol, 52(1), 56–65. DOI: 10.4103/ijp.IJP11520.
   PubMed Web of Science ®Google Scholar
• Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 1–11. (just-accepted), https://doi.org/10.1080/07391102.2020.1753580
   PubMed Web of Science ®Google Scholar
• Sinha, S. K., Shakya, A., Prasad, S. K., Singh, S., Gurav, N. S., Prasad, R. S., & Gurav, S. S. (2020). An in-silico evaluation of different saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics, 1–13. (just-accepted), https://doi.org/10.1080/07391102.2020.1762741
   PubMed Web of Science ®Google Scholar
• Tse, G. M.-K., To, K.-F., Chan, P. K.-S., Lo, A. W. I., Ng, K.-C., Wu, A., Lee, N., Wong, H.-C., Mak, S.-M., Chan, K.-F., Hui, D. S. C., Sung, J. J.-Y., & Ng, H.-K. (2004). Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). Journal of Clinical Pathology, 57(3), 260–265. https://doi.org/10.1136/jcp.2003.013276
   PubMed Web of Science ®Google Scholar
• van de Veerdonk, F., Netea, M. G., van Deuren, M., van der Meer, J. W., de Mast, Q., Bruggemann, R. J., & van der Hoeven, H. (2020). Kinins and cytokines in COVID-19: A comprehensive pathophysiological approach. Preprints, 2020, 2020040023. https://doi.org/10.20944/preprints202004.0023.v1
   Google Scholar
• Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2020.04.037
   Web of Science ®Google Scholar
• Wahedi, H. M., Ahmad, S., & Abbasi, S. W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–16. (just-accepted), https://doi.org/10.1080/07391102.2020.1762743
   PubMed Web of Science ®Google Scholar
• Weiss, S. R., & Navas-Martin, S. (2005). Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiology and Molecular Biology Reviews: MMBR, 69(4), 635–664. https://doi.org/10.1128/MMBR.69.4.635-664.2005
   PubMed Web of Science ®Google Scholar
• Yi, Y., Lagniton, P. N., Ye, S., Li, E., & Xu, R. H. (2020). COVID-19: What has been learned and to be learned about the novel coronavirus disease. International Journal of Biological Sciences, 16(10), 1753–1766. https://doi.org/10.7150/ijbs.45134
   PubMed Web of Science ®Google Scholar